Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7C2L

S protein of SARS-CoV-2 in complex bound with 4A8

Summary for 7C2L
Entry DOI10.2210/pdb7c2l/pdb
EMDB information30276
Related PRD IDPRD_900017
DescriptorSpike glycoprotein, heavy chain of 4A8, light chain of 4A8, ... (6 entities in total)
Functional Keywordsace2-b0at1 complex, membrane protein, membrane protein-immune system complex, membrane protein/immune system
Biological sourceSevere acute respiratory syndrome coronavirus 2 (2019-nCoV)
More
Total number of polymer chains9
Total formula weight668918.58
Authors
Yan, R.H.,Zhang, Y.Y.,Guo, Y.Y.,Li, Y.N.,Xia, L.,Zhou, Q. (deposition date: 2020-05-08, release date: 2020-07-01, Last modification date: 2024-10-16)
Primary citationChi, X.,Yan, R.,Zhang, J.,Zhang, G.,Zhang, Y.,Hao, M.,Zhang, Z.,Fan, P.,Dong, Y.,Yang, Y.,Chen, Z.,Guo, Y.,Zhang, J.,Li, Y.,Song, X.,Chen, Y.,Xia, L.,Fu, L.,Hou, L.,Xu, J.,Yu, C.,Li, J.,Zhou, Q.,Chen, W.
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.
Science, 369:650-655, 2020
Cited by
PubMed Abstract: Developing therapeutics against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could be guided by the distribution of epitopes, not only on the receptor binding domain (RBD) of the Spike (S) protein but also across the full Spike (S) protein. We isolated and characterized monoclonal antibodies (mAbs) from 10 convalescent COVID-19 patients. Three mAbs showed neutralizing activities against authentic SARS-CoV-2. One mAb, named 4A8, exhibits high neutralization potency against both authentic and pseudotyped SARS-CoV-2 but does not bind the RBD. We defined the epitope of 4A8 as the N-terminal domain (NTD) of the S protein by determining with cryo-eletron microscopy its structure in complex with the S protein to an overall resolution of 3.1 angstroms and local resolution of 3.3 angstroms for the 4A8-NTD interface. This points to the NTD as a promising target for therapeutic mAbs against COVID-19.
PubMed: 32571838
DOI: 10.1126/science.abc6952
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.1 Å)
Structure validation

226707

PDB entries from 2024-10-30

PDB statisticsPDBj update infoContact PDBjnumon